Clinical Trial Update: A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278 [Phase 1]

View source ↗

Summary

A Phase 1 repeat-dose study in healthy volunteers evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of GSK356278; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• GSK356278

Snippet

Sponsor: GlaxoSmithKline | Conditions: Huntington Disease | Phase 1 | Status: COMPLETED